@ulrich_nm Profile picture

Ulrich Neumann

@ulrich_nm

Passionate about patient access, partnerships, disruption in pharma. Access & Scientific Policy @ J&J, Founder @pharmvivo. Views my own, RT≠ endorsement.

Similar User
Sachin H. Jain, MD, MBA photo

@sacjai

UCSF IHPS photo

@UCSF_IHPS

Barbie Zelizer photo

@bzelizer

Sabrina Corlette photo

@SabrinaCorlette

Lanhee J. Chen photo

@lanheechen

David E. Albert, M.D photo

@DrDave01

Sarah Lueck photo

@sarahL202

NKF - Northern CA photo

@NKFNorthernCA

Matt Fiedler photo

@MattAFiedler

Ameet Sarpatwari photo

@AmeetSarpatwari

Inmaculada (Inma) Hernández photo

@ihdezdelso

Bagel & Donut Co photo

@BagelDonutCo1

Jessica Federer photo

@jjfeds

David Meyers photo

@djmeyers2

SCHARR HEDS photo

@SCHARRHEDS

Pinned

Save the Date! Monday, Aug 21 at 11am EDT for a groundbreaking Reuters webinar on "RE-DESIGNING US HEALTH INSURANCE." events.reutersevents.com/healthcare/jan… Janssen joins Geisinger and Blue Cross and Blue Shield of Louisiana to address benefit design and systemic health disparities. Sign up!


Ulrich Neumann Reposted

NEW: America is a rich country. Britain is a poor country with one wealthy region. People love to compare the UK to Mississippi, but it’s far more informative to look at UK subnationally, too. London ranks fairly well, the rest of the country does not 👉 ft.com/content/e5c741…

Tweet Image 1

Ulrich Neumann Reposted

“That correlation between reducing amyloid and slowing, however fractionally, patients’ cognitive decline is both a validation of the long-debated amyloid hypothesis and a positive sign for other medicines in development.” Bravo!!!

Detailed data on Alzheimer’s therapy from Eisai, Biogen hold up to scientific scrutiny, via @damiangarde and @JonathanWosen statnews.com/2022/11/29/det…



Ulrich Neumann Reposted

After reading coverage of @Alnylam pausing development its anti-TTR RNAi drug Amvuttra for treatment of #Stargardt, my colleague Tess and I wrote a deeper analysis & respond to critics who think this has nothing to do with the IRA. #9213asap @SenateHELP rapport.bio/all-stories/al…


Ulrich Neumann Reposted

Everyone can win with the fastest car, fews can win with a back-marker, but only one driver can do the impossible. P17-P7 today, Fernando Alonso

Tweet Image 1

Ulrich Neumann Reposted

Research from @npc, PQA and @universityofri examined factors that impact #patient #adherence to oral anticancer medications. The findings highlight #access barriers and #healthequity concerns. Read more: bit.ly/3zCwmZJ

Tweet Image 1

Ulrich Neumann Reposted

Critical discussion...

As policymakers implement the largest healthcare changes since the ACA, IVI says rather than hardcoding one way to assess value, we must incorporate equitable, patient-centric, flexible & transparent approaches to assessing value for health technologies. thevalueinitiative.org/press-release-…



Ulrich Neumann Reposted

Best discussion yet of drug pricing problem & what Congress has done wrong & could do right. Shoutout to @costplusdrugs of course as illustrative of “the problem” & shoutout to @SenSchumer for defunding R&D while lining pockets of middlemen. @KarenVanNuys esquire.com/news-politics/…


Ulrich Neumann Reposted

“The use of deductibles assumes that all medical spending is the same and that the system should disincentivize all of it, starting over each Jan. 1” Excellent piece from @aaronecarroll on some of the backwards logic of high deductibles. h/t @DrugChannels nytimes.com/2022/07/07/opi…


Ulrich Neumann Reposted

Peter's got some good points here 👇

Congress is on the verge of gutting cancer & Alzheimer’s R&D w/ a few careless lines in reconciliation bill b/c seemingly everyone is tired of trying to do the right thing & thinks no one will notice. You’ll never want to contribute to a campaign after this reading this. 1/20



Ulrich Neumann Reposted

This is pretty bizarre, no? "Hey, we think that the impact on innovation will be 50% greater than we estimated last week, but we're not going to explain why." cc: @PeterKolchinsky

CBO has now revised this number to 15, w/o much explanation: "Note revised July 13, 2022; No budgetary estimates were changed in the table above. The original note indicated that 10 fewer drugs would be introduced over the next 30 years instead of 15, as indicated here."



Ulrich Neumann Reposted

The unfortunate truth for Democrats is that political incentives are not in their favor when it comes to Joe Manchin. He came into the Biden presidency on shaky ground with WV voters, and opposing Ds' agenda has paid dividends in his state. morningconsult.com/2022/04/25/joe…

Tweet Image 1

Ulrich Neumann Reposted

No Supreme Court Justice nominee will ever be able to use the words “precedent” or “settled law again”. About anything!


Ulrich Neumann Reposted

#OurAMA condemns SCOTUS's decision to overturn nearly a half century of precedent protecting patients’ right to critical reproductive health care — representing an egregious allowance of government intrusion into the medical examination room. spr.ly/6016ziBqo

Tweet Image 1

Ulrich Neumann Reposted

It takes a monster to kill children. But to watch monsters kill children again and again and do nothing isn’t just insanity—it’s inhumanity.


Ulrich Neumann Reposted

The newly created Disinformation Board should review this tweet, or maybe they need to form a new Non Sequitur Board instead. Raising corp taxes is fine to discuss. Taming inflation is critical to discuss. Mushing them together is just misdirection.

You want to bring down inflation? Let’s make sure the wealthiest corporations pay their fair share.



Ulrich Neumann Reposted

My impression is that with loosening of mask restrictions and recommendations we’re also seeing many more URIs from non-Covid respiratory viruses? Many of us who haven’t had a cold in a long time, that honeymoon may be ending? Good idea to use those wipes they hand you on planes


Loading...

Something went wrong.


Something went wrong.